CEO & President
JC Medical and Genesis MedTech
Providence, Rhode Island, United States
Dr. Mark Turco is an experienced clincal, scientific and business executive.
Dr. Turco spent over 7 years working for large cap medical device companies, serving as Vice President and Chief Medical Officer of the vascular and neuro franchises for Medtronic, Inc. and Covidien, plc and then as the Chief Innovation Officer at the University of Pennsylvania.
Dr. Turco is currently the CEO of JC Medical and President, North American Vascular Intervention for Genesis Medtech. JC Medical is a fully owned subsidiary of Genesis MedTech and a clinincal stage company with its initial offering a TAVR valve for the treatment of paitnets with Aortic Regurgitation.
He practiced as an interventional cardiologist in the Washington, D.C. area for 16 years, serving as Director of the Cardiovascular Research Center at Washington Adventist Hospital, Takoma Park, MD. Dr. Turco has numerous publication to his credit.
Disclosure information not submitted.
Panel Discussion | Challenges and Opportunities for Innovation in 2023
Sunday, March 10, 2024
9:12 AM – 9:27 AM ET
TREATMENT OF AORTIC INSUFFICIENCY: THE NEXT TAVR FRONTIER
Monday, March 11, 2024
4:08 PM – 5:10 PM ET
Panel Discussion: Treatment of Aortic Insufficiency | The Next Frontier
Monday, March 11, 2024
4:40 PM – 5:10 PM ET
CRT 2024 BEST INNOVATIONS COMPETITION
Monday, March 11, 2024
2:40 PM – 5:30 PM ET
FINAL REFERRAL and PANEL DISCUSSION
Monday, March 11, 2024
5:16 PM – 5:25 PM ET
J-Valve for Aortic Regurgitation
Tuesday, March 12, 2024
8:56 AM – 9:04 AM ET